| P2093 | author name string | E Barth | |
| | J Clawson | |
| P2860 | cites work | Autoimmune hepatitis, from mechanisms to therapy | Q33342074 |
| | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 |
| | Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared | Q34477263 |
| | Treatment strategies in autoimmune hepatitis | Q34936764 |
| | Diverse manifestations and evolving treatments of autoimmune hepatitis. | Q36311459 |
| | The validity and importance of subtypes in autoimmune hepatitis: a point of view | Q36690069 |
| | The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases | Q37691471 |
| | Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 |
| | Histologic features in autoimmune hepatitis. | Q44366596 |
| | The diagnostic importance of ACTH. | Q51060789 |
| | Population-based epidemiology study of autoimmune hepatitis: a disease of older women? | Q51539848 |
| | Autoimmune Hepatitis | Q56210456 |
| | Failure of customary treatment in chronic active liver disease: causes and management | Q67498569 |
| | Liver transplantation for autoimmune hepatitis: a long-term pathologic study | Q74071291 |
| | Pathogenesis of autoimmune hepatitis | Q78322634 |
| | Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group | Q80820259 |
| | Controlled trial of prednisone and azathioprine in active chronic hepatitis | Q93735616 |
| P433 | issue | 3 | |
| P921 | main subject | rituximab | Q412323 |
| | autoimmune hepatitis | Q786844 |
| P304 | page(s) | 502-509 | |
| P577 | publication date | 2010-11-23 | |
| P1433 | published in | Case reports in gastroenterology | Q27722663 |
| P1476 | title | A Case of Autoimmune Hepatitis Treated with Rituximab | |
| P478 | volume | 4 | |